Whole genome sequencing identifies novel contributors to drug resistance among Korean isolates
Whole genome sequencing and clinical information from tuberculosis patients at Masan National Tuberculosis Hospital were compared in this investigation. whole genome sequencing plays a major role in diagnosing and managing tuberculosis in patients. The rapid and thorough information on their resistance to several drugs in the market might pave the way for developing novel candidates when needed. Overall, whole genome sequencing has significant advantages regarding expected strain anti-tuberculosis drug susceptibility, genetic contextual, epidemiologic data, and evidence of laboratory cross-contamination risk.